Archive for the ‘Uncategorized’ Category

Petition Update: Nearly 19,000 Have Signed So Far Against Eugene Shapiro Being on the TBDWG – Also, Updates

https://www.change.org/p/tick-borne-disease-working-group-keep-eugene-shapiro-off-the-federal-tbdwg?

Go to link for more information as well as to sign the petition if you haven’t already.

Also:  https://madisonarealymesupportgroup.com/2019/05/19/if-true-shapiro-on-tbd-working-group-will-outrage-lyme-community/  In Comment section you can listen to Shapiro in action on a youtube video. The man is clearly mad, deceived, or evil.

For more on the TBDWG:  https://madisonarealymesupportgroup.com/2018/12/14/tbdwg-on-surveillance-in-humans/

https://madisonarealymesupportgroup.com/2018/12/11/tbdwg-reviews-over-700-public-comments-uses-zero/

https://madisonarealymesupportgroup.com/2018/07/27/tbdwg-draft-report/

https://madisonarealymesupportgroup.com/2018/05/12/tweets-of-tbd-working-group-may-10-2018-meeting/

https://madisonarealymesupportgroup.com/2018/05/16/summary-of-may-15-tbd-working-group-meeting-in-tweets/

https://madisonarealymesupportgroup.com/2018/12/18/gla-counters-idsa-criticisms-of-tbdwg-report/

Please sign if you haven’t already and send a clear message to HHS.

Recently Dorothy Kupcha Leland came out with the following article:  https://www.lymedisease.org/what-gives-tbdwg/

In short, she states, “Things are getting weird with the TBDWG,” because HHS was supposed to come out with the names of new members of the group by April but all that happened was an announcement by the IDSA finally on May 15 that Dr. Eugene Shapiro, had been named to the Working Group. When asked for confirmation from TBDWG staff, they said no decision had been made.

Her following questions deserve answers:

  • did the IDSA hallucinate Shapiro’s appointment—or
  • were they privy to decisions that have not been made public? 
  • why did the IDSA feel sure enough to enshrine this revelation on its website?
  • if not true, why wouldn’t HHS ask them take it down? It’s been sitting there for the world to see, for two weeks.

For Lorraine Johnson’s (Lymedisease.org) letter to the TBDWG in advance of it’s June 4, 2014 meeting:

https://www.lymedisease.org/effective-representation-tbdwg/

LYMEPOLICYWONK: Will patients be effectively represented on Working Group?

 

Lyme Disease Changed My Relationship With The Outdoors

https://www.outsideonline.com/2395555/lyme-disease-changed-my-relationship-outdoors

Lyme Disease Changed My Relationship with the Outdoors

For Blair Braverman, physical activity was a given. Until it wasn’t.

Photo: Sarah Marshalldogs

 

 

Septic Shock Caused by RMSF in Suburban Texas Patient With Pet Dog Exposure: A Case Report

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091339/

. 2018; 19: 917–919.
Published online 2018 Aug 4. doi: 10.12659/AJCR.909636
PMCID: PMC6091339
PMID: 30076285

Septic Shock Caused by Rocky Mountain Spotted Fever in a Suburban Texas Patient with Pet Dog Exposure: A Case Report

Abstract

Patient: Female, 45

Final Diagnosis: Rocky mountain spotted fever

Symptoms: Altered mental state • ataxia • dyspnea • fever • headache

Objective:

Unusual clinical course

Background:

Rocky Mountain spotted fever (RMSF) is associated with high mortality and requires prompt identification and treatment to ensure better outcomes.

Case Report:

We describe an advanced case of RMSF in a 45-year-old female patient with pet dog exposure who presented with altered mental status, dyspnea, and ataxia progressing to septic shock and acute hypoxic respiratory failure requiring intubation and mechanical ventilation.

Conclusions:

This case illustrates the importance of keeping RMSF in the differential diagnosis in patient populations outside of the usual geographic areas of incidence in the appropriate clinical setting.

___________________

**Comment**

This is what can happen when diagnosis is delayed.

This woman that lived in the suburbs had a 7-day history of fevers associated with headache, arthralgias, nausea, fatigue, and neck pain, but did NOT have the tell-tale blotchy RMSF rash.

Two days later, she worsened with confusion, combativeness, dyspnea, and ataxia. She got multiple recent bug bites from her pet dogs sleeping in her bed. The dogs were not up to date on flea and tick medication but were healthy and showed no sign of illness.
  • Rule #1:  Do NOT sleep with pets.  The risk is too great.
  • Rule #2:  If you choose to have pets, make sure you treat them if they go outdoors.  The risk is too great.
  • Rule #3:  Doctors need to start treating this plague with the respect it deserves and frankly should keep it in the back of their minds AT ALL TIMES.
Positive findings were R. typhi IgM 1: 1024 (normal <1: 64), R. Rickettsii IgM 1: 1024 (normal <1: 64), IgG 1: 128 (normal <1: 64), and echovirus Ab 1: 80 titer (normal <1: 80). The Rickettsial titers were repeated for possible cross-reactivity and R. typhi antibodies were noted to be negative (<1: 64).
Although R.typhi was ruled out due to cross-reactivity, I believe we will start seeing more of this strain in the future.
The patient improved on doxycycline, the drug of choice for RMSF and was discharged.
Why isn’t there a full-out media blitz on this like there was on Zika?

Have You Been Told It’s All In Your Head? The New Biology of Mental Illness

https://kellybroganmd.com/told-head-new-biology-mental-illness/

Have You Been Told It’s All In Your Head? The New Biology of Mental Illness.

© Kelly Brogan MD. This work is reproduced and distributed with the permission of Kelly Brogan MD. For more articles, sign up for the newsletter at kellybroganmd.com.

____________________

**Comment**

Great article.  Lyme/MSIDS patients have been told, “It’s all on your head,” for over 40 years.  Time for change!

https://madisonarealymesupportgroup.com/2019/05/27/uk-woman-isolated-pumped-full-of-anti-psychotics-told-its-all-in-her-head-until-finally-diagnosed-with-lyme/

https://madisonarealymesupportgroup.com/2017/09/21/its-all-in-your-head-until-finally-a-lyme-diagnosis/

https://madisonarealymesupportgroup.com/2019/05/15/life-with-lyme-disease-a-womans-15-year-journey-to-diagnosis/

https://madisonarealymesupportgroup.com/2019/04/22/its-just-crazy-why-is-lyme-disease-treatment-so-difficult-to-find-in-mississippi/

https://madisonarealymesupportgroup.com/2017/06/30/child-with-lymemsidspans-told-by-doctors-she-made-it-all-up/

https://madisonarealymesupportgroup.com/2019/02/16/lyme-is-all-in-your-head-a-wake-up-call-to-mental-health-professionals/

How many more have to suffer like this before the medical world wakes up?

 

 

 

 

Johns Hopkins Lyme Disease Awareness Webinar – May 30, 2019

https://jhjhm.zoom.us/webinar/register/WN_c78Ja46pRpCPAl0B0m1wzA

Webinar banner

 Microsoft (Outlook)

Topic

Lyme Disease Awareness Webinar

Description

Join Center Directors, John Aucott, MD, and Mark Soloski, PhD, for an update on Lyme disease and other tick-borne infections.

Find out what you need to know about Lyme disease and tick-borne illness to help keep you and your loved ones safe while enjoying the outdoors.

Learn what to do if bitten by a tick, how to recognize a Lyme disease rash, and how innovative research is addressing this growing epidemic.

You will not want to miss this informative and timely webinar with Dr. Aucott and Dr. Soloski.

May 30, 2019 12:00 PM in Eastern Time (US and Canada)

Speakers

photo of John Aucott, MD
John Aucott, MD
Director, Johns Hopkins Lyme Disease Research Center
John Aucott, MD, is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine and Director of the Johns Hopkins Lyme Disease Research Center. He has been involved in care of patients and research in Lyme disease since joining the Johns Hopkins faculty in 1996. Dr. Aucott’s research is focused on discovering better diagnostic and prognostic tests for Lyme disease and the development of new treatment strategies for patients with chronic symptoms. He is the Principal Investigator for the SLICE studies, a research program that investigates the impact of Lyme disease on health outcomes and the human immune system. The biorepository of blood samples generated by the SLICE studies are a nationally recognized resource that has become the basis of groundbreaking collaborations studying the microbiology and immune pathophysiology of Lyme disease.
photo of Mark Soloski, Ph.D.
Mark Soloski, Ph.D.
Co-Director, Johns Hopkins Lyme Disease Research Center
Mark Soloski, PhD, is a Professor of Medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine and Co-Director for Basic Research for the Johns Hopkins Lyme Disease Research Center. Dr. Soloski joined the Johns Hopkins School of Medicine faculty in 1983 and holds joint appointments in the School of Medicine’s Departments of Pathology and Molecular Biology and Genetics as well as the Department of Molecular Microbiology and Immunology in the School of Public Health. Dr. Soloski is interested in the role that infection plays in setting the stage for chronic immune mediated inflammatory diseases. His work includes investigating the human immune response to infection with Borrelia burgdorferi, the causative agent of Lyme disease. His efforts employ genomic, proteomic, and complex immune phenotyping approaches to understand how the immune system contributes to the symptoms and severity of human Lyme disease.